WASHINGTON--A report released by the Congressional Office of Technology Assessment (OTA) says that screening for prostate cancer has not yet been proven to save lives. The report concluded: "Because scientific knowledge is limited, but the consequences of prostate cancer and its treatment are serious, an informed and reasonable patient could equally well decide to have screening or forego it." Nevertheless, OTA said that it would be reasonable for Medicare to consider reimbursement for such screening.
WASHINGTON--A report released by the Congressional Office of TechnologyAssessment (OTA) says that screening for prostate cancer has notyet been proven to save lives. The report concluded: "Becausescientific knowledge is limited, but the consequences of prostatecancer and its treatment are serious, an informed and reasonablepatient could equally well decide to have screening or foregoit." Nevertheless, OTA said that it would be reasonable forMedicare to consider reimbursement for such screening.
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Navigating Treatment Intensification in Metastatic Hormone-Sensitive Prostate Cancer
A patient case of a 50-year-old man with hormone-sensitive prostate cancer sparked a debate among oncologists regarding the best course of action.